Join our daily newsletter At The Bell to receive exclusive market insights
- Mediland Pharm (MPH) has partnered with five Sydney-based pharmacies to distribute the company’s health and well-being products
- Mediland-branded products will now be stocked by Market City Pharmacy, Haymarket Pharmacy, Pavilion Pharmacy Town Hall, and Sydney City Pharmacy
- Alongside this news, the company has made its Mediland app available on both Apple and Android devices in an effort to spur online sales
- And in an effort to preserve cash during the COVID-19 pandemic, the company has reduced rental expenses and has frozen all fees for its non-executive directors
- Mediland Pharm shares are steady today, trading for 13 cents each
Health and wellness retailer Mediland Pharm (MPH) has partnered with five Sydney-based pharmacies to distribute the company’s products.
As well as health and wellness products, the company sells cosmetics, jewellery and wool. Mediland currently operates three retail stores located in Australia and another in New Zealand, catering largely to the tourism market.
The company’s Mediland-branded products will now be stocked by Market City Pharmacy, Haymarket Pharmacy, Pavilion Pharmacy Town Hall, and Sydney City Pharmacy.
The new distributors will stock a range of Mediland wellness products including Glucosamine, Bio-Squalene, Eye Excel, Respiraclear.
The news comes after Mediland announced a similar agreement with Priceline Clemton Park earlier this year.
Alongside this news, the company announced it’s intensifying its focus on the online retail sector. Online commerce has recently seen a boost in traffic, as pandemic-related quarantine restrictions drive consumers online.
Consequently, the company has made its Mediland App available on both Apple and Android devices in an effort to spur online sales further.
Chairman of Mediland, Peter French, is pleased with the company’s progress in expanding its income streams.
“Securing five Sydney-based retail pharmacies to stock and sell our increasing range of health and well-being products indicates the potential to expand further in this channel,” Peter said.
“We are particularly pleased to see the rewards of our commitment over the past year to implement and grow our e-commerce platform. The company aims to continue to expand and further diversify our revenues whilst reducing costs where possible to offset the challenges from the COVID-19 pandemic,” he continued.
In an effort to preserve cash during the pandemic, the company has reduced rental expenses and has frozen all fees for its non-executive directors.
Mediland Pharm shares are steady today, trading for 13 cents each at 11:52 am AEST.
